Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|12|1|3-21

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.12, Iss.1, 2016-02, pp. : 3-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases

By Bedu Elodie   Wahli Walter   Desvergne Béatrice  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Peroxisome Proliferator-Activated Receptor Science

By  

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 267-280

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor &ggr; Agonists as Insulin Sensitizers: From the Discovery to Recent Progress

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-11 ,pp. : 1483-1507

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Evaluation of Peroxisome Proliferator-Activated Receptor /&bgr;Dual Agonists for the Treatment of Type 2 Diabetes

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 1, 2007-01 ,pp. : 27-32

Bentham Science Publishers

Access to resources Recommend Favorite